Ikena Oncology, Inc. (IKNA)
NASDAQ: IKNA · Real-Time Price · USD
1.140
+0.010 (0.88%)
At close: May 12, 2025, 4:00 PM
1.140
0.00 (0.00%)
After-hours: May 12, 2025, 4:00 PM EDT
Ikena Oncology Market Cap
Ikena Oncology has a market cap or net worth of $55.01 million as of May 12, 2025. Its market cap has decreased by -11.63% in one year.
Market Cap
55.01M
Enterprise Value
-52.43M
1-Year Change
-11.63%
Ranking
Category
Stock Price
$1.14
Market Cap Chart
Since the IPO on March 26, 2021, Ikena Oncology's market cap has decreased from $553.41M to $55.01M, a decrease of -90.06%. That is a compound annual growth rate of -42.87%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 54.53M | -31.10% |
| Dec 31, 2024 | 79.14M | -16.75% |
| Dec 29, 2023 | 95.07M | -1.43% |
| Dec 30, 2022 | 96.44M | -78.58% |
| Dec 31, 2021 | 450.27M | -18.64% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 659.45B |
| Johnson & Johnson | 371.06B |
| UnitedHealth Group | 345.29B |
| AbbVie | 326.08B |
| Novo Nordisk | 297.79B |
| Abbott Laboratories | 231.82B |
| Novartis AG | 214.71B |
| AstraZeneca | 211.14B |